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Introduction 
Thebroad antibiotic resistance of hospital pathogens, 
inducing thigh index of human morbidity andmortality, 
as well as hospital costs.1 The developed antibiotic 
resistant strains of bacteria to antibiotic therapy imply 
the demand for alternative treatments for infectious 
disease. One strategy that may lead to improved 
antimicrobial treatment is the application of antimicrobial 
photodynamic therapy (aPDT).2 aPDT involves the use of 
a chemical photosensitizer or a nontoxic photoactivatable 
dye, visible light, and reactive oxygen. The therapy is 
based on the energy (absorbed as light via the intracellular 
photosensitizer) transferred to the oxygen molecules 
producing extremely reactive mediation, such as singlet 
oxygen and superoxide, that are noxious to the cells.3,4
History of Photodynamic Therapy
The origin of the light therapy found as an alternative 
treatment in medical profession and surgery from ancient 
to contemporary time. Phototherapy trace its root back 
to ancient Greece, Egypt and India, however not applied 
for centuries. Ultimately, it has been unearthed via the 
westerly society at the outset of the 20th century by a 
Danish physicist, Niels Finsen. He succeeded to prove 
the usage of photodynamic therapy by applying heat and 
light filtered through a carbon lamp for the treatment of 
cutaneous tubercles known as lupus vulgaris.5 The idea 
of necrobiosis caused by action and reaction between 
light and chemicals were the earliest described by Raab 
in Munich. He found that chemical changes in the 
presence of a pigment called acridine light, inducing 
the death of a paramecium.6 The next work that was 
done in the laboratory by Von Tappeiner, coined the 
term “Photodynamic action” was revealed that oxygen is 
essential for this operation. The next few years Thomas 
Dougherty et al at the Roswell Park Cancer Institute 
in clinical examined PDT. Photodynamic therapy was 
confirmed by the Food and Drug Administration in 1999 
to treat pre-cancerous skin lesions in the head and face.7
The Mechanism of Action of Photodynamic Therapy
PDT comprise the application of visible light, combined 
with a photosensitizer (PS) and with the oxygen (Figure 
1).8 PDT is based on the interplay of visible light and a 
photosensitizer agent which under photo-activation 
generate short lived cytotoxic species in site. After 
stimulation, the photosensitizer is converted from singlet 
to triplet state by an intersystem crossing process which, 
in turn, reacts with surrounding molecules to produce 
radical species and hydrogen peroxide, or transfers its 
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Figure 1. The Mchanism of Antibacterial Photodynamic Therapy. 
Photosensitizers can be preferentially uptaken by bacteria, 
accumulating inside the bacteria and in the cytoplasm membranes, 
or in the proximity. The photosensitizer in its ground singlet state is 
exposed to light of a appropriate wavelength and attract a photon. 
Then, the photosensitizer transferral energy from light to molecular 
oxygen to produce singlet oxygen and free radicals that are cytotoxic 
to cells.
Table 1. Photosensitizers Used in Antimicrobial Photodynamic Therapy
Photosensitizer Chemical Structure Referance
Methylene blue (4, 13)
Toluidine blue (4, 13)
Indocyanine Green (14)
Curcumin (15)
Rose bengal (4, 13)
Chlorin(e6) (16)
energy to molecular oxygen to manufacture singlet 
oxygen. Oxygen species that are capable of eliminating 
target cells by oxidative stress to cell membranes and 
other cellular parts.9
Photosensitizers
An optimally photosensitizers ought to have favorable 
structural features including physical, chemical, 
and biological. Many optical photosensitizers for 
photodynamic therapy have been tested in vitro as well 
as in vivo conditions. Optimal photosensitizers for aPDT 
of porphyrins derivatives, chlorine and phthalocyanine 
are porphycenes and phenothiazines’ colors such as 
toluidine blue O (TBO), methylene blue (MB) and Azure 
is applied. Optimal photosensitizers’ cationic tetrapyrrole 
contain  quaternary groups  based  on  foundations such 
as  porphyrin  and  phthalocyanine, and  spherical C60 
molecules are produced. The mechanism of all optimal 
photosensitizers operation  or polymer photosensitizers 
conjugate  to light absorption or self-promoted uptake 
pathway, respectively. 
In this process, at first  the cationic molecules, Mg+2 and 
Ca+2 are displaced in outer membrane, and then followed 
by the light photosensitizer absorption via permeability 
of outer membrane, and finally  of the cell membrane is 
destructed Table 1.10-12
Light Sources Used in Photodynamic Therapy
Photodynamic therapy requires a light source for 
triggering the photosensitizer exposures with a low power 
visible light at a particular wavelength. More the optical 
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photosensitizers are actuated by red light in 630 nm and 
700 nm wavelengths. Corresponding to a light influence 
depth of 0.5 cm to 1.5.17,18
Methods
A review of pertinent literatures was carried out in 
PubMed and Scopus to determine the efficiency of aPDT 
applied in the reduction of microbial infection. Sixty 
relevant documents were retrieved from PubMed, Scopus 
by inserting “Antimicrobial photodynamic therapy” 
and “Bacterial infection” and “photodynamic therapy” 
keywords.
Results
Application of Photodynamic Therapy In Vitro
For this review, the summary of the selected studies, the 
authors’ name, the general description of the studies, and 
the results are presented. The effect of photodynamic 
inactivation in 14 clinical strains Staphylococcus aureus 
resistant to methicillin (MSRA) and 26 clinical strains 
Staphylococcus aureus susceptible to methicillin (MSSA) 
were evaluated by Kashef et al. The results showed that 
the toluidine blue- and MB photodynamic inactivation on 
MRSA strains to reduce ranging from1-1.3  log10 – 0.7-1 
log10 CFU/mL, respectively. In the case of MSSA strains 
the achieved results for toluidine blue- and MB 
photodynamic inactivation included viable count 
reduction ranging approximately from 1.1 to 1.3 log10 – 
0.7- 0.9 log10 CFU/mL, respectively.
19 In another study, 
Maisch et al investigated the impact of photodynamic 
therapy with photosensitizers (XF73, XF70,CTP1) on 
strains of S. aureus resistant to methicillin. The findings 
showed that concentrations (0.005 μM) of photosensitizers, 
using light (13.7 J/cm2) for 10 minutes to reduce a 3log10 
(>99.9%) of bacteria.20 Grinholc et al evaluated  the 
bactericidal effects of the photodynamic inactivation with 
a porphoporphyrin photosensitizer at 624 nm wavelength 
with an energy density of (0.2 J/cm2) on 40 clinical isolates 
of methicillin-resistant S. aureus and 40 clinical isolates of 
methicillin-sensitive S. aureus isolated patients admitted 
to the hospital in Gdansk. The results of the study 
indicated the reduction of 3log10 in the number of 
bacteria.21 the effect of aPDT with Radachlorin 
photosensitizer on S. aureus was studied by Fekrazad et al. 
The findings showed that the number of viable S. aureus 
was decreased to 6.28 log10 in a study group that was used 
for photosensitizers with laser light.22 Kashef et al studied 
the photodynamic inactivation influence on Escherichia 
coli (ATCC25922) and clinical resistant strains of E. coli 
using photosensitizers of MB and toluidine blue O (TBO). 
MB (50 μg/mL) with a laser light of red (163.8 J/cm2) 
capable of reducing 53.1% and 37.6% in the number of 
viable E. coli (ATCC25922) and drug resistant E. coli (the 
initial number of bacteria was 104-105 Cfu/mL). Moreover, 
TBO (50 μg/mL) and a laser dose of 46.68 J/cm2 killed 
98.2% and 83.2% of E. coli (ATCC25922) and drug-
resistant E. coli.23 In another study, Ragas et al studied the 
photodynamic efficiency on the plankton condition in A. 
baumannii. The results showed that the decreasing in the 
number of A. baumannii in plankton condition was 
2-3log10 reported after photodynamic inactivation with 2 
photosensitizers of TBO and MB.24 Kashef et al assessed 
the efficacy of photodynamic therapy on A. baumannii. 
The findings of the study showed the reducing in 
logarithmic growth of live cells after photodynamic 
inactivation with MB and TBO (TBO) for 5 strains of 
Acinetobacter baumannii was between (1.3log10), (3.5–
2.4log10), (2.9-2.2log10) and (2.6log10). Furthermore, 
photodynamic inactivation reduced the minimum 
inhibitory concentrations of growth inhibitors into 
Azithromycin, Imipenem, Ciprofloxacin and Gentamicin 
antibiotics.25 Donnelly et al performed a photodynamic 
test of 2 photosensitizers of TBO and meso-Tetra(N-
methyl-4-pyridyl) porphine tetra tosylate (TMP) at a 
concentration of 5 mg/mL on 5 strains of Pseudomonas 
aeruginosa isolated from cystic fibrosis, and the laser light 
killed 99.99% of bacteria.26 Garcia et al investigated the 
effect of photodynamic therapy using a Hypericin 
sensitizer against biofilms formed of methicillin-resistant 
and sensitive staphylococci. The results of this study 
showed planktonic forms destruction in 10 minutes 
exposed to laser light.27 The study by Miyabe et al 
evaluated the impact of photodynamic therapy using 
photosensitizers MB (3mM) and gallium-aluminium 
lasers at a wavelength of 660 nm red light with an energy 
density and time of 35 mW, 10 J, and 285 seconds, on S. 
aureus. The findings showed  the number of bacteria 
(4.89-6.83 log10 CFU/mL) decreased in relation to the 
initial concentration of bacteria.28 Grinholc et al 
investigated the effect of photodynamic therapy using a 
protoporphyrin 25 μM photosensitizer with laser 
radiation at a wavelength of 624 nm on the methicillin-
resistant (MRSA) and sensitive strains (MSSA) of S. 
aureus. The results of this study indicated that there was a 
reduction of 0-3 log10 and 0.2-3 log10 strains of MRSA and 
MSSA in the number of bacteria, respectively.21 Sharma et 
al assessed the effectiveness of aPDT on S. aureus biofilm 
formation. In this study, a TBO photosensitizer was used 
at concentrations of 10-80 μm and light source diode laser 
with a 640 nm wavelength. The results showed that at 40 
μM concentration, biofilm was destroyed and has the 
least cytotoxic effect in cells.29 Li et al investigated the 
effect of photodynamic therapy with 5-aminolevulinic 
acid (ALA) photosensitizer and a concentration of 40 mM 
and an optical source laser with 635 nm wavelength for 
activating ALA at doses (0, 100, 200, 300 J/cm2) used. The 
results of this study showed that ALA without exposure to 
light or red light does not affect bacterial biofilm. 
However, a significant number of cells in the biofilm was 
inactivated during radiation with different doses of red 
light in the presence of 5-aminolevulinic acid, and at the 
dosage of 300 J/cm2, all bacteria (99.99%) were killed.30 
Journal of Lasers in Medical Sciences  Volume 9, Number 3, Summer 2018 157
                                       Antimicrobial Photodynamic Therapy and Control of Bacterial Infections
Khalil et al reported the effect of laser light on MRSA 
strains using TBO photosensitizer at a concentration of 
50 μg/mL and a HeNe laser light with a wavelength of 
632.8 nm in 1, 5, 10 minutes. The findings of the study 
indicated that 100% of the bacteria were killed in 15 
minutes. Antibiotic resistance patterns of these strains 
were different before and after laser radiation, so that they 
were resistant to gentamicin 10 μg prior to the laser 
irradiation, and had an intermediate resistance to 
vancomycin. Moreover, after laser radiation, they became 
sensitive to these antibiotics.31 Tang et al showed the effect 
of photodynamic therapy on clinical isolates of MRSA 
strains and S. aureus strain ATCC 25923 under the 
conditions of using TBO photosensitizer at concentrations 
(80 μM-400 μM) and Pl-ce6 at a concentration of (8 μM) 
and an optical source of laser 600 nm wavelength with 
doses (10-30 J/cm2) for 30 minutes. The results of this 
study showed that Pl-ce6 and TBO at the concentration (8 
μM, 30 J/cm2- 80 μM, 30 J/cm2) induced killing of MRSA 
(4log10 and 3log10) and S. aureus (ATCC 25923 (3log10-
2log10)).
32 Pourhajibagher et al determined the efficacy of 
sub-lethal photodynamic therapy with the ability to form 
biofilm and the metabolic activity of Enterococcus faecal 
under in vitro conditions by using indocyanine green 
photosensitizer at concentrations (2 mg/mL) and TBO 
and MB at a concentration of 0.2 mg/mL with a diode 
laser as light source for TBO and MB and indocyanine 
green were 635 nm-200 mW, 660 nm-150 mW, 810 nm-
200 mW, respectively. The findings showed that PDT-ICG 
and PDT-MB and TBO-PDT sub-lethal reduces 42.8%, 
22.6%, and 19.5% of biofilms, the sub-lethal dose of PDT-
ICG and PDT-MB and TBO PDT reduced 98%, 94%, 82% 
of metabolic activity, in Enterococcus faecal, respectively.33 
In another study, Pourhajibagher et al investigated the 
effect of sub-lethal photodynamic therapy on 
Porphyromongus gingivalis isolated from endodontic 
infections using diode laser light. The findings of this 
study showed that MB-sPAD (25 μg/ml-117.18 J/cm2) 
and (50-100 μg/mL-117.18 J/cm2) significantly inhibited 
the growth of P. gingivalis than the control group.34 Boluki 
et al studied the effect of photodynamic therapy (TBO 
with 630 nm LED laser light) with colistin on A. baumannii 
pandrug resistant strains. The results of this study showed 
that the effect of TBO+LED significantly reduced the 
growth of bacterium. Although after calculating sublethal 
effects, the expressions of Pmr A-Pmr B genes were 
evaluated through real-time PCR method, it was indicated 
that rates were reduced in 6.1 to 4.1 fold.35 The efficacy of 
photodynamic therapy on the formation of biofilm P. 
gingivalis was evaluated by Pourhajibagher et al using the 
inducianin green photosensitizer. The results showed that 
indosanine green at a concentration of 62.5-1000 μg/mL 
reduced a significant number of bacteria, which decreased 
compared to the control group (23.2%-93.7%).36 Soukos 
et al investigated the effect of photodynamic therapy on E. 
faecalis in biofilm formed at root infections under the 
laboratory conditions. The findings of the study suggest 
that 97% of the bacteria were reduced when they were 
exposed to  red laser light  and MB at a concentration of 
(25 mg/mL).37
Application of Photodynamic Therapy In Vivo
Maisch et al investigated the intrusive and antibacterial 
effects of XF 73 (porphyrin cationic photosensitizer) on S. 
aureus (MRSA) in the pig’s skin. They applied 2 methods 
for conducting the study. In the first method, they placed 
the bacterium in a XF73 solution, and then placed it on 
the pig’s skin.  In the second method, they placed the 
bacterium on the pig’s skin, then placed the XF73 on the 
pig’s skin for just 1 hour of dressing. Photoinactivation in 
the first method led to a 3-log10 reduction in S. aureus, 
while in the second method S. aureus reduced by1-log10.
38 
Orenstein et al used a mixture of deuteroporphyrin-
hemin, and successfully disinfected burns infected with 
S. aureus.39 Fonseca et al contaminated single-root teeth 
with E. faecalis and incubated them for 48 hours at 35°C. 
Then the teeth placed in a TBO solution (0.0125%) for 5 
minutes and for photodynamic therapy used 660 nm and 
50 mW light irradiation. The reduction in the number 
of CFUs in the treated group was about 99.9, while in 
untreated group there was an increase of 2.6%.40 Sivieri-
Araujo et al in a survey examined the effectiveness of 
antimicrobial photodynamic upon tissue responses and 
cytokine production using a curcumin photosensitizer 
agent. The study process was conducted in which saline 
polyethylene tubes were introduced as control samples 
and sodium hypochlorite 5% and aPDT containing 500 
mg/mL curcumin photosensitizer was put in the back of 
the connective tissue of the wistar rats. Seven, 15, 30, 60 
and 90 days after planting, animals were exterminated 
and the tubes were removed with surrounding tissue. The 
results of the study indicated that the tissues reacted at days 
7. Antimicrobial photodynamics increased the amount 
of IL-1B at all times (P <0.05). IL-6 levels were highest 
at a 90-day period with aPDT.41 Jung et al investigated 
the effect of PDT on Hemophilus influenza in vivo, and 
Streptococcus pneumoniae in Meriones unguiculatus rats. 
Twenty microliters of the bacterial solution (106 CFU) 
injected into the bullae under sterile conditions. PDT was 
performed 2 days after infection by injection of 20 μL a 
Hematoporphyring (1 mg/mL) derivative photogeram 
inside the bulla and exposure to a 632 nm laser light with 
90 J power. PDT was effective in eliminating S. pneumonia 
in 87%, whereas it was effective in killing of H. influenza 
in 50% of the infected bullae with otitis media with 
effusion.42 In a preliminary clinical trial, 13 patients orally 
administered 20 mg/kg 5-aminolevulinic, and 45 minutes 
later, the antrum area of the stomach was irradiated by 
an endoscope with blue laser (50 J/cm2-405 nm).  Their 
results showed that in the samples that were exposed to 
radiation, the amount of H. pylori was lower,  compared 
to the control areas.43  Geralde et al using PDT treated 
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pneumonia caused by S. pneumoniae.  Their hairless 
mice with S. pneumoniae were infected. After 2 days 
with antimicrobial photodynamics, infected mice were 
treated. In the control group, between 103-104 CFU/mL 
of bacteria in mice was grown. However, in the treatment 
group with antimicrobial photodynamic, bacteria did 
not grow in 80% of the infected animals. Based on the 
results, the animals after 50 days were re-examined. In 
the PDT group, no death was observed, but in the control 
group, 60% of the infected mice were died.1 Ahangari et 
al compared the effects of antibacterial calcium hydroxide 
and photodynamic therapy on E. faecalis in teeth with 
periapical lesions under in vivo conditions. This study was 
performed on 20 patients, and did not succeed in treating 
endodontic. In this study, group 1 (n=10) was treated with 
antimicrobial photodynamic (880 nm diode laser with 50 
mg/mL MB), while calcium hydroxide was used in group 
2 for 1 week. Control samples were taken with sterile paper 
points and rotary F3 pro taper. The findings of this survey 
showed that the number of bacteria were declined in both 
groups after intervention (P < 0.001). However, there was 
no important difference in the number of colonies among 
the two groups.44 The study by Wu et al evaluated the effect 
of photodynamic therapy via using chlorin e6 against P. 
aeruginosa keratitis in mice under in vivo conditions. 
With the scratch on the mouse corneal epithelial tissue, 
the mouse corneal was infected with P. aeruginosa (strain 
PA54). After 24 hours, the chlorine (e6) at concentration 
0% (control group), 0.01%, 0.05%, 0.1% with red light 
compound (PDI) were used. After 2 days, the eyes of 
the mice were picked up for counting the bacteria. The 
results showed that the number of bacteria in the group 
treated with PDI significantly decreased.45 de Almeida et 
al investigated the therapeutic impact of photodynamic 
therapy in none diabetic (n=120) and diabetic (n=120) 
rats with the experimental periodontal disease. Then, 
infected rats were divided into saline washing groups with 
saline solution, washing with TBO, laser radiation (660 
nm, 24 J) and PDT (toluiden blue + laser radiation). After 
that, 10 animals from the experimental groups and the 
subgroups were evaluated in days 7, 15 and 30. The results 
of this study showed that less bone loss (0.33 ± 0.05 mm2, 
0.35 ±0.06 mm2, 0.27 ± 0.07 mm2) and SRP (1.11 ± 0.11 
mm2, 0.84 ± 0.12 mm2, 0.97 ± 0.13 mm2) was observed 
in days 7, 15, and 30, respectively (P < 0.05). In the TBO 
group bone loss was (0.51 ± 0.12 mm2, 0.70 ± 0.13 mm2, 
0.64 ± 0.08 mm2) in days 7, 15 and 30, respectively. In the 
laser group bone loss was (0.59 ± 0.03 mm2, 0.61 ± 0.04 
mm2, 0.61 ± 0.03 mm2) in days 7, 15, and 30 of evaluation. 
Finally, the group D, which was treated with PDT, showed 
less bone loss (0.27 ± 0.06 mm2, 0.24 ± 0.02 mm2, 0.29 ± 
0.03 mm2) in days 7, 15 and 30, respectively. Therefore it 
was much less than other groups. Findings of this study 
confirmed that, PDT can be utilized as a supplementary 
to periodontal treatment.46
Conclusion
The data obtained of this study demonstrated that 
bacteria were susceptible to photosensitizer (MB, 
TBO, indocyanine green) in the presence of light diode 
laser. This review suggests that the PDT may useful for 
treatment of infection diseases. PDT is a technique that 
has been shown to be effective in vivo and invitro against 
pathogen bacteria. Doubtless, aPDT has noticeable in the 
nearby prospect not only for the treatment of infections, 
but also in non-clinical utilization in different fields.
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